Risk-adaptive therapy guided by dynamic ctDNA in nasopharyngeal carcinoma - Nature

Nature, Published online: 11 March 2026; doi:10.1038/s41586-026-10244-wA clinical trial testing whether monitoring ctDNA clearance during treatment for nasopharyngeal cancer could be used to inform...

By · · 1 min read
Risk-adaptive therapy guided by dynamic ctDNA in nasopharyngeal carcinoma - Nature

Source: Nature

Nature, Published online: 11 March 2026; doi:10.1038/s41586-026-10244-wA clinical trial testing whether monitoring ctDNA clearance during treatment for nasopharyngeal cancer could be used to inform decisions about an individual’s subsequent therapeutic programme shows promising results.